Literature DB >> 24815353

Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Noton K Dutta1, Peter B Illei2, Sanjay K Jain1, Petros C Karakousis3.   

Abstract

We sought to develop and characterize a novel paucibacillary model in mice, which develops necrotic lung granulomas after infection with Mycobacterium tuberculosis. Six weeks after aerosol immunization with recombinant Mycobacterium bovis bacillus Calmette-Guerin overexpressing the 30-kDa antigen, C3HeB/FeJ mice were aerosol infected with M. tuberculosis H37Rv. Six weeks later, mice were treated with one of three standard regimens for latent tuberculosis infection or tumor necrosis factor (TNF)-neutralizing antibody. Mouse lungs were analyzed by histological features, positron emission tomography/computed tomography, whole-genome microarrays, and RT-PCR. Lungs and sera were studied by multiplex enzyme-linked immunosorbent assays. Paucibacillary infection was established, recapitulating the sterilizing activities of human latent tuberculosis infection regimens. TNF neutralization led to increased lung bacillary load, disrupted granuloma architecture with expanded necrotic foci and reduced tissue hypoxia, and accelerated animal mortality. TNF-neutralized mouse lungs and sera showed significant up-regulation of interferon γ, IL-1β, IL-6, IL-10, chemokine ligands 2 and 3, and matrix metalloproteinase genes. Clinical and microbiological reactivation of paucibacillary infection by TNF neutralization was associated with reduced hypoxia in lung granulomas and induction of matrix metalloproteinases and proinflammatory cytokines. This model may be useful for screening the sterilizing activity of novel anti-tuberculosis drugs, and identifying mycobacterial regulatory and metabolic pathways required for bacillary growth restriction and reactivation.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815353      PMCID: PMC4076462          DOI: 10.1016/j.ajpath.2014.03.008

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  Disease model: pulmonary tuberculosis.

Authors:  D N McMurray
Journal:  Trends Mol Med       Date:  2001-03       Impact factor: 11.951

2.  Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

Authors:  T C Mitchell; D Hildeman; R M Kedl; T K Teague; B C Schaefer; J White; Y Zhu; J Kappler; P Marrack
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

3.  Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide.

Authors:  Karen Vandal; Pascal Rouleau; Annie Boivin; Carle Ryckman; Mariève Talbot; Philippe A Tessier
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

5.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

6.  Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

Authors:  Jamie Harper; Ciaran Skerry; Stephanie L Davis; Rokeya Tasneen; Mariah Weir; Igor Kramnik; William R Bishai; Martin G Pomper; Eric L Nuermberger; Sanjay K Jain
Journal:  J Infect Dis       Date:  2011-12-23       Impact factor: 5.226

7.  Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.

Authors:  Zahoor Ahmad; Lee G Klinkenberg; Michael L Pinn; Mostafa M Fraig; Charles A Peloquin; William R Bishai; Eric L Nuermberger; Jacques H Grosset; Petros C Karakousis
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

8.  Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis.

Authors:  Cristina Vilaplana; Elena Marzo; Gustavo Tapia; Jorge Diaz; Vanesa Garcia; Pere-Joan Cardona
Journal:  J Infect Dis       Date:  2013-04-05       Impact factor: 5.226

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas.

Authors:  Ciaran Skerry; Jamie Harper; Mariah Klunk; William R Bishai; Sanjay K Jain
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

View more
  28 in total

1.  Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.

Authors:  Bas C Mourik; Gerjo J de Knegt; Annelies Verbon; Johan W Mouton; Hannelore I Bax; Jurriaan E M de Steenwinkel
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 2.  Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Authors:  Ashley V Veatch; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2017-09-11       Impact factor: 17.079

Review 3.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Int J Antimicrob Agents       Date:  2014-09-16       Impact factor: 5.283

Review 5.  Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.

Authors:  Molly A Matty; Francisco J Roca; Mark R Cronan; David M Tobin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 6.  Immunology studies in non-human primate models of tuberculosis.

Authors:  JoAnne L Flynn; Hannah P Gideon; Joshua T Mattila; Philana Ling Lin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

7.  A tuberculosis ontology for host systems biology.

Authors:  David M Levine; Noton K Dutta; Josh Eckels; Charles Scanga; Catherine Stein; Smriti Mehra; Deepak Kaushal; Petros C Karakousis; Hugh Salamon
Journal:  Tuberculosis (Edinb)       Date:  2015-06-30       Impact factor: 3.131

8.  Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.

Authors:  Yu-Min Chuang; Noton K Dutta; Chien-Fu Hung; T-C Wu; Harvey Rubin; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

Review 10.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.